#Canada #financial results #Calgary #Nanalysis Scientific #NMR Spectrometers

Nanalysis Scientific Corp. Presents Q2 2026 Results

Nanalysis Scientific Corp. (TSXV: NSCI, FRA: 1N1), renowned for its innovative portable Nuclear Magnetic Resonance (NMR) spectrometers and imaging technology, recently released its financial performance for the second quarter ending June 30, 2026. Following a resilient operational strategy, the Company has reported noteworthy achievements that signal a promising outlook for the remainder of the year.

Key Financial Highlights

For the second quarter of 2026, Nanalysis generated a revenue of $9.7 million, reflecting a growth of 1.5% when compared to the same period in 2025. A significant aspect of this growth is the positive Adjusted EBITDA of $0.9 million, marking a stark recovery from an EBITDA loss of $0.5 million in the previous year.

Breakdown of Revenue Sources

• - Product Sales: The revenue from product sales accounted for $2.8 million but experienced a slight decline of 3.6% compared to the same quarter in 2025.
• - Services Revenue: Revenues from services increased by 3.9% to reach $5.8 million, while flow-through revenue also saw a rise of 2.9% with $1.1 million recorded.

These figures indicate a resilient performance despite some setbacks in product sales due to reduced third-party equipment sales and a lowered demand for NMR benchtops in Q1.

Strategic Improvements

Sean Krakiwsky, CEO of Nanalysis, expressed optimism regarding the company's trajectory. "We are encouraged by the ongoing improvements in our operating performance. Our Security Services have shown enhanced margins, while Scientific Equipment is benefiting from better manufacturer efficiencies. Cost discipline across the organization has played a critical role," he stated.

The company has been actively leveraging its Security Services segment, which has shown remarkable growth from strategic operational enhancements implemented in the past year. Gross margins for Security Services climbed to 12% for the quarter, up from 10% last year, highlighting the significant impact of improved operational efficiencies.

Operational Highlights

A few vital initiatives contributing to Nanalysis' operational success include:

• - Debt Management: The Company remains in compliance with all financial covenants related to its ATB term loan, which has been essential for financial stability and operational growth.
• - Distributor Network Enhancements: There is an ongoing effort to bolster the international distributor network for Scientific Equipment, with projections for distributor-led sales to potentially double compared to the previous year.
• - Government Partnerships: Strengthening ties with entities like PrairiesCan has facilitated funding support and loan restructuring, which provides crucial capital for advancing technology and operations.

Future Outlook

Looking ahead, Nanalysis aims to maintain its focus on operational improvements while navigating broader market challenges. Krakiwsky said, "We believe the actions taken over the past year to strengthen our operational efficiency will reflect positively in our performance as we work through 2026."

Investors interested in understanding these developments more thoroughly can participate in the live conference call scheduled for August 24, 2026, at 10 A.M. ET, where company leaders will delve deeper into the results and future strategy.

• ---

Overall, Nanalysis' second quarter results demonstrate resilience, strategic growth, and a keen focus on operational excellence, positioning it for continued progress in the upcoming quarters.